Nicotinell

Nicotine, the active ingredient in Nicotinell, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers who wish to quit by delivering a controlled dose of nicotine to reduce withdrawal symptoms and cravings.\n\nGNH India supplies Nicotinell as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell is a nicotine replacement therapy used to support smoking cessation.\n\nSmoking cessation: helps adult smokers reduce cravings and withdrawal symptoms during a quit attempt.\nRelapse prevention: assists individuals who have recently quit to maintain abstinence.\nAdjunct to counseling: used together with behavioral support to improve overall quit rates.

Common Side Effects:\n- Skin irritation at the application site\n- Itching or redness\n- Burning sensation\n- Insomnia or vivid dreams\n- Headache\n- Nausea\n\nSerious or Rare Side Effects:\n- Allergic reaction such as rash or swelling\n- Tachycardia or hypertension\n- Chest pain\n- Severe dermatitis\n- Seizures (rare)\n- Signs of nicotine overdose (e.g., vomiting, dizziness)

Before using Nicotinell, consider the following precautions.\n\nAssess cardiovascular status: patients with recent heart attack or uncontrolled hypertension should use under medical supervision.\nAvoid use in pregnancy: safety not established; discuss with a healthcare provider.\nDo not use while breastfeeding: nicotine can be transferred to the infant.\nDo not apply to damaged or irritated skin: may increase nicotine absorption.\nDo not use multiple patches simultaneously: risk of nicotine overdose.\nStore at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nicotinell may interact with other medicines.\n\nMajor Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis.\n- Other nicotine‑containing products (gum, lozenges, inhalers): risk of nicotine overdose.\n- CYP2A6 inhibitors (e.g., cimetidine): may raise nicotine plasma levels.\n\nModerate Interactions (Monitor Closely):\n- Alcohol: may enhance nicotine's cardiovascular effects.\n- Antidepressants such as bupropion: may increase seizure risk.\n- Antihypertensive agents: nicotine may reduce their efficacy.